<DOC>
	<DOCNO>NCT00800267</DOCNO>
	<brief_summary>Safety efficacy study compare fix combination latanoprost-timolol component part .</brief_summary>
	<brief_title>A Study Glaucoma Ocular Hypertension Patients Within United States</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Unilateral bilateral primary open angle glaucoma , capsular glaucoma , pigmentary glaucoma ocular hypertension . Patients currently IOP reduce therapy : IOP great equal 25mmHg ( Ltwo IOP determination prestudy separate least one hour ) OR Patients without IOP reduce therapy : IOP great equal 30mmHg ( two IOP determination prestudy separate least one hour ) . History acute angle closure closed/barely open anterior chamber angle . Current use contact lens . Ocular surgery argon laser trabeculoplasty ( ALT ) within three month prior prestudy visit . Ocular inflammation/infection occur within three month prior prestudy visit . Hypersensitivity benzalkonium chloride component study drug solution . Other abnormal ocular condition symptom prevent patient enter study , accord investigator 's judgement . Patients condition treatment Bblocking agent contraindicate : cardiac failure , sinus bradycardia , second third degree atrioventricular block . Patients condition treatment Bblocking agent contraindicate : bronchial asthma , history bronchial asthma chronic obstructive pulmonary disease . Inability adhere treatment/visit plan . Have participate clinical study within one month prior prestudy visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>ocular hypertension</keyword>
	<keyword>Fixed combination latanoprost-timolol</keyword>
	<keyword>latanoprost</keyword>
	<keyword>timolol</keyword>
</DOC>